Levy Richard S

Average Profitability
321.79%
Insider Buys Quantity
4
Insider Buys Sum
$234,463.27
Insider Sells Quantity
38
Insider Sells Sum
$66.24M

Insider Activity of Levy Richard S

According to the SEC Form 4 filings, Levy Richard S, being in a position of

  1. director at Madrigal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 21000 shares for $6.09M,
    over all time since 2017-08-21, has bought 9100 shares for $145,803, and sold 43489 shares for $12.68M.

The largest purchase of all time was on 2020-03-20 and amounted to 2000 shares of Kodiak Sciences Inc. for $88,660.

The largest sale of all time was on 2014-02-13 and amounted to 191309 shares of Incyte Corporation for $12.7M.

Biography of Levy Richard S

No biography is available at this moment.

2024-11-07SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
5,000
0.0224%
$350.00$1.75M-7.55%
2024-11-01SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
5,000
0.0217%
$300.94$1.5M+5.83%
2024-04-01SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
11,000
0.0557%
$257.49$2.83M-6.15%
2023-01-17SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
22,489
0.1227%
$293.15$6.59M-21.53%
2020-03-20PurchaseKodiak Sciences Inc.
KOD
director
2,000
0.0044%
$44.33$88,660+40.96%
2017-08-23PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
2,000
0.0154%
$16.12$32,236+580.11%
2017-08-22PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
3,550
0.0287%
$16.12$57,209+613.24%
2017-08-21PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
3,550
0.0283%
$15.88$56,358+614.47%
2016-01-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0025%
$60.09$473,149-20.19%
2015-12-07SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0024%
$62.25$490,157-24.24%
2015-11-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,872
0.0028%
$67.42$530,691-18.61%
2015-10-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0026%
$70.31$553,582-27.43%
2015-09-11SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
8,602
0.0047%
$130.00$1.12M-37.51%
2015-09-08SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0025%
$68.61$540,235-31.76%
2015-08-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,872
0.0027%
$65.14$512,743-18.46%
2015-07-15SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
140,434
0.046%
$68.89$9.68M-26.04%
2015-07-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0025%
$62.66$493,385-10.32%
2015-06-19SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
40,000
0.0131%
$62.96$2.52M-3.74%
2015-06-08SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0026%
$62.95$495,668-2.61%
2015-05-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
14,824
0.0049%
$58.88$872,763+5.34%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.